Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lintao Xia
Observed name:
Lin-Tao Xia
Institution:
Shanghai University of Traditional Chinese Medicine
Observed institutions:
Shanghai University of Traditional Chinese Medicine,
Shanghai Institute of Pharmaceutical Industry
ORCID:
0000-0001-7332-8806
Observed ORCID:
0000-0001-7332-8806
OpenAlex ID:
A5037586014
Mitochondrial DNA-activated cGAS-STING pathway in cancer: Mechanisms and therapeutic implications
2024
·
Lintao Xia
, Xiuli Yan
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
74
Multiscale identification of DNASE1L3 as a key target in MASLD progression to hepatocellular carcinoma
2025
·
Lintao Xia
, Xiuli Yan
, et al.
·
Pathology - Research and Practice
·
5
Development of a Novel Chemoenzymatic Process for 3-(Methylsulfonyl)- l -phenylalanine Phenylmethyl Ester─A Key Intermediate of Lifitegrast (Xiidra)
2024
·
Chuanjun Wu
, Heng Guo
, et al.
·
Organic Process Research & Development
·
2
Immune response to DNA and RNA: structural insights, molecular mechanisms, and therapeutic targeting
2026
·
Lintao Xia
, Yixi Wang
, et al.
·
Molecular Biomedicine
PDF
Deep Learning-Based 30-Day Mortality Prediction in Critically Ill Bone and Bone Marrow Metastasis Patients: A Multicenter Retrospective Cohort Study
2025
·
Yixi Wang
, Lintao Xia
, et al.
·
Current Oncology
PDF
Targeting Osteoporosis: Multi-Omics Mendelian Randomization Reveals Key Apoptosis-Related Genes in Blood and Skeletal Muscle as Predictive and Therapeutic Targets
2024
·
Yixi Wang
, Lintao Xia
, et al.
·
SSRN Electronic Journal
Development of a New Process for Tulobuterol Hydrochloride
2023
·
Chuan-Jun Wu
, Peng Peng
, et al.
·
Pharmaceutical Fronts
PDF
Show more works
View as search
Works count:
7
Citation count:
81
H-index:
2
I10-index:
1
Year
Topic
Type